Crawford Tara M, Andersen Chad C, Stark Michael J
The Robinson Research Institute, The University of Adelaide, Adelaide 5006, Australia.
The Department of Neonatal Medicine, The Women's and Children's Hospital, North Adelaide 5006, Australia.
Children (Basel). 2022 Dec 16;9(12):1980. doi: 10.3390/children9121980.
Transfusion exposure increases the risk of death in critically ill patients of all ages. This was thought to relate to co-morbidities in the transfusion recipient. However, donor characteristics are increasingly recognised as critical to transfusion recipient outcome with systematic reviews suggesting blood donor sex influences transfusion recipient health. Originally focusing on plasma and platelet transfusions, retrospective studies report greater risks of adverse outcomes such as transfusion related acute lung injury in those receiving products from female donors. There is increasing awareness that exposure to red blood cells (RBCs) poses a similar risk. Recent studies focusing on transfusion related outcomes in extremely preterm newborns report conflicting data on the association between blood donor sex and outcomes. Despite a renewed focus on lower versus higher transfusion thresholds in neonatal clinical practice, this group remain a heavily transfused population, receiving on average 3-5 RBC transfusions during their primary hospital admission. Therefore, evidence supporting a role for better donor selection could have a significant impact on clinical outcomes in this high-risk population. Here, we review the emerging evidence for an association between blood donor sex and clinical outcomes in extremely preterm newborns receiving one or more transfusions.
输血暴露会增加各年龄段重症患者的死亡风险。这被认为与输血受者的合并症有关。然而,供体特征越来越被认为对输血受者的结局至关重要,系统评价表明献血者性别会影响输血受者的健康。回顾性研究最初关注血浆和血小板输血,报告称接受女性供体血液制品的患者出现输血相关急性肺损伤等不良结局的风险更高。人们越来越意识到,输注红细胞(RBC)也存在类似风险。最近针对极早产儿输血相关结局的研究报告了关于献血者性别与结局之间关联的相互矛盾的数据。尽管新生儿临床实践中重新关注较低与较高的输血阈值,但这一群体仍然是大量输血的人群,在其首次住院期间平均接受3至5次红细胞输血。因此,支持更好地选择供体的证据可能会对这一高危人群的临床结局产生重大影响。在此,我们综述了接受一次或多次输血的极早产儿中献血者性别与临床结局之间关联的新证据。